Apitolisib
- Generic Name
- Apitolisib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H30N8O3S
- CAS Number
- 1032754-93-0
- Unique Ingredient Identifier
- 1C854K1MIJ
- Background
Apitolisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Prostate Cancer, Renal Cell Carcinoma, and Endometrial Carcinoma, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath